There was no significant difference in the serum concentration of S100A15 between the whole group of patients suffering from HS (156.1 ± 133.8 pg/mL) and the control group (153.9 ± 134.8 pg/mL) (p > 0.05) (Figure 3a). This evidence concerns the gene S100A7A and histiocytic sarcoma.